Austin Mark John 4
4 · Perspective Therapeutics, Inc. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
Austin Mark John
Controller/Prin Fin&Acct Offic
Transactions
- Exercise/Conversion
Common stock
2024-04-23$0.36/sh+30,000$10,800→ 84,030 total - Exercise/Conversion
Stock option (right to buy)
2024-04-23−30,000→ 120,000 totalExercise: $0.36Exp: 2032-08-09→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The Stock Option is fully vested.